APA

Moreland L. W., Pratt P. W., Mayes M. D., Postlethwaite A., Weisman M. H., Schnitzer T., Lightfoot R., Calabrese L., Zelinger D. J. & Woody J. N. (19951212). Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate. : Arthritis and rheumatism.

Chicago

Moreland L W, Pratt P W, Mayes M D, Postlethwaite A, Weisman M H, Schnitzer T, Lightfoot R, Calabrese L, Zelinger D J and Woody J N. 19951212. Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate. : Arthritis and rheumatism.

Harvard

Moreland L. W., Pratt P. W., Mayes M. D., Postlethwaite A., Weisman M. H., Schnitzer T., Lightfoot R., Calabrese L., Zelinger D. J. and Woody J. N. (19951212). Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate. : Arthritis and rheumatism.

MLA

Moreland L W, Pratt P W, Mayes M D, Postlethwaite A, Weisman M H, Schnitzer T, Lightfoot R, Calabrese L, Zelinger D J and Woody J N. Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate. : Arthritis and rheumatism. 19951212.